Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

Clinical trial NCT05514002 · COMPLETED

Trial details

NCT number: NCT05514002
Sponsor: Centers for Disease Control and Prevention
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2022-09-13
Primary completion: 2023-12-31
Enrollment: 3988

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.